SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-182655
Filing Date
2020-06-29
Accepted
2020-06-29 18:45:23
Documents
13
Period of Report
2020-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d917807d8k.htm   iXBRL 8-K 46870
2 EX-3.1 d917807dex31.htm EX-3.1 176703
  Complete submission text file 0001193125-20-182655.txt   382024

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA advm-20200623.xsd EX-101.SCH 3066
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20200623_lab.xml EX-101.LAB 18124
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20200623_pre.xml EX-101.PRE 11402
6 EXTRACTED XBRL INSTANCE DOCUMENT d917807d8k_htm.xml XML 3421
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 20998672
SIC: 2836 Biological Products, (No Diagnostic Substances)